Biocon Biologics launches biosimilar adalimumab in US

Adalimumab is used to treat certain inflammatory diseases like rheumatoid arthritis. Humira contributed $21.2 billion in sales to AbbVie for 2022, making it the world ’s top-selling non-COVID prescription drug until recently. HULIO is available at a list price (Wholesale Acquisition Cost) of 5% below the current Humira list price. Adalimumab-fkjp is also available at a list price of approximately 85% below the current Humira list price.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news